Ara
Toplam kayıt 2, listelenen: 1-2
Clinical implications of fluvoxamine and fluoxetine with sigma-1 receptor chaperone activity in the treatment of neuropsychiatric disorders
(Nova Science Publishers, Inc., 2015)
Selective serotonin reuptake inhibitors (SSRIs) are used as therapeutic drugs for a number of neuropsychiatric diseases throughout the world. Although all SSRIs act by blockading serotonin transporters, leading to elevated ...
Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders
(Springer International Publishing Ag, 2017)
Accumulating evidence suggests that sigma-1 receptors play a role in the pathophysiology of neuropsychiatric diseases, as well as in the mechanisms of some selective serotonin reuptake inhibitors (SSRIs). Among the SSRIs, ...